Japanese Encephalitis and West Nile and Other Flavivirus Infections

Tropical Infectious Diseases

Volumn 1, Issue , 2006, Pages 823-830

  Watts, Douglas M ^a,b   Granwehr, Bruno P ^c   Shope, Robert E ^d   Solomon, Tom ^e   Tesh, Robert B ^b  

^a WHO Collab Center for Tropical Dis   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36448954021     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06668-9.50078-8     Document Type: Chapter

References (74)

1. Hall RA, Scherret JH, Mackenzie JS Kunjin virus: An Australian variant of West Nile. Ann NY Acad Sci 2001, 951:153-160.
2. Mackenzie JS, Barrett AD, Deubel V The Japanese encephalitis serological group of flaviviruses: A brief introduction to the group. Curr Top Microbiol Immunol 2002, 267:1-10.
3. Burke DS, Leake CJ Japanese encephalitis. The Arboviruses: Epidemiology and Ecology 1988, 3:68. CRC Press, Boca Raton, FL, 83. T.P. Monath (Ed.).
4. Halstead SB, Jacobson J Japanese encephalitis. Adv Virus Res 2003, 61:103-138.
5. Endy TP, Nisalak A Japanese encephalitis virus: Ecology and epidemiology. Current Top Microbiol Immunol 2002, 267:11-48.
6. Tsai TF Factors in the changing epidemiology of Japanese encephalitis and West Nile virus. Factors in the Emergence of Arbovirus Diseases 1997, 178-179. Elsevier, Paris. J.F. Saluzzo, B. Dodet (Eds.).
7. Solomon T, Nguyen MD, Kneen R, et al. Japanese encephalitis. J Neurol Neurosurg Psychiatr 2000, 68:405-415.
8. Vaughn DW, Hoke CH The epidemiology of Japanese encephalitis: Prospects for prevention. Epidemiol Rev 1992, 14:197-221.
9. Chambers TJ, Tsai TF, Pervikov Y, et al. Vaccine development against dengue and Japanese encephalitis: Report of a World Health Organization Meeting. Vaccine 1997, 15:1494-1502.
10. Mackenzie JS, Johansen CA, Ritchie AS, et al. Japanese encephalitis as an emerging virus: The emergence and spread of Japanese encephalitis virus in Australasia. Curr Top Microbiol Immunol 2002, 267:49-73.
11. Hoke C, Nisalak A, Sangawihipa N, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988, 319:608-614.
12. Umenai T, Krysko R, Bektimirov TA, et al. Japanese encephalitis: Current worldwide status. Bull World Health Org 1985, 63:625-631.
13. Hayes CG 1989. West Nile fever. The Arboviruses: Epidemiology and Ecology 1988, 3:59-88. CRC Press, Boca Raton, FL. T.P. Monath (Ed.).
14. Hayes CG West Nile virus: Uganda, 1937, to New York City, 1999. Ann NY Acad Sci 2001, 951:25-37.
15. Murgue B, Zeller H, Deubel V The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr Top Microbiol Immunol 2002, 267:195-221.
16. Turell MJ, Sardelis MR, Dohm DJ, et al. Potential vectors of West Nile virus in North America. Ann NY Acad Sci 2001, 951:317-424.
17. Petersen LR, Marfin AA, Gubler DJ West Nile virus. JAMA 2003, 290:524-528.
18. Gubler DJ The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002, 33:330-342.
19. Nash D, Mostashari F, Miller J, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001, 344:1807-1814.
20. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999, 286:2333-2337.
21. Gould LH, Fikrig E West Nile virus: A growing concern. J Clin Invest 2004, 113:1102-1107.
22. Watson JT, Gerber SI West Nile virus: A brief review. Pediatr Infect Dis J 2004, 23:357-358.
23. Granwehr BP, Lillibridge KM, Higgs S, et al. West Nile virus: Where are we now?. Lancet Infect Dis 2004, 4:547-556.
24. Price WH, Thind IS Protection against West Nile virus induced by a previous injection with dengue virus. Am J Epidemiol 1971, 94:596-607.
25. Tesh RB, Arroyo J, Travassos Da Rosa AP, et al. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg Infect Dis 2002, 8:1392-1397.
26. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet 2001, 358:254-255.
27. Tsai TF, Popovici F, Cernescu C, et al. West Nile encephalitis epidemic in Southeastern Romania. Lancet 1998, 352:767-771.
28. Bemer YN, Lang R, Chowers MY Outcome of West Nile in older adults. J Amer Geriatr Soc 2002, 50:1844-1846.
29. Petersen LR, Marfin AA West Nile virus: A primer for the clinician. Ann Intern Med 2002, 137:173-179.
30. Vidwan G, Bryant KK, Puri V, et al. West Nile virus encephalitis in a child with left-side weakness. Clin Infect Dis 2003, 37:E91-E94.
31. Solomon T Current concepts: flavivirus encephalitis. New Engl J Med 2004, 351:370-378.
32. Solomon T, Kneen R, Dung NM, et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 1998, 351:1094-1097.
33. Solomon T, Winter PM Neurovirulence and host factors in flavivirus encephalitis-Evidence from clinical epidemiology. Arch Virol (Suppl) 2004, 18:161-170.
34. Solomon T, Dung NM, Kneen R, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002, 125:1084-1093.
35. Monath TP, Tsai TF Flaviviruses. Clinical Virology 2002, 1097-1151. ASM Press, Washington, DC. 2nd ed. D.D. Richman, R.J. Whitley, F.G. Hayden (Eds.).
36. Solomon T, Vaughan DW Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Current Topics in Microbiology and Immunology: Japanese Encephalitis and West Nile Virus Infections 2002, 171-194. Springer, Berlin. V. Deubel (Ed.).
37. Mirsa K, Kalita J Seizures in Japanese encephalitis. J Neurol Sci 2001, 190:57-60.
38. Shieh WJ, Guarner J, Layton M, et al. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect 2000, 6:370-372.
39. Sharma S, Mathur A, Prakash V, et al. Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin Exp Immunol 1991, 85:85-89.
40. Hubalek Z Comparative symptomatology of West Nile fever. Lancet 2001, 358:254-255.
41. Solomon T Recent advances in Japanese encephalitis. J Neurovirol 2003, 9:274-283.
42. Deubel V, Fiette L, Gounon P, et al. Variations in biological features of West Nile viruses. Ann NY Acad Sci 2001, 951:195-206.
43. Diamond MS, Shrestha B, Marri A, et al. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003, 77:2578-2586.
44. Burke DS, Lorsomrudee W, Leake CJ, et al. Fatal outcome in Japanese encephalitis. Am Trop Med Hyg 1985, 34:1203-1210.
45. Burke DS, Nisalak A, Ussery MA, et al. Kinetics of Japanese encephalitis virus immunoglobulin M and G antibodies in human serum and cerebrospinal fluid. J Infect Dis 1985, 151:1093-1099.
46. Solomon T, Thao LT, Dung NM, et al. Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J Clin Microbiol 1998, 36:2030-2034.
47. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003, 3:376-379.
48. Theiler M, Downs WG Arthropod-Borne Viruses of Vertebrates 1973, Yale University Press, New Haven, CT.
49. Halstead SB, Rojanasuphot S, Sangkawibha N Original antigenic sin in dengue. Am Trop Med Hyg 1983, 32:154-156.
50. Howe DK, Vodkin MH, Novak RJ, et al. Use of the polymerase chain reaction for the sensitive detection of St. Louis encephalitis viral RNA. J Virol Methods 1992, 36:101-110.
51. Technical Information on Japanese Encephalitis and Guidelines for Treatment 1979, World Health Organization, WHO Regional Office, Southeast Asia, New Delhi.
52. Gea-Banaclothe J, Johnson RT, Bagic A, et al. West Nile virus: Pathogenesis and therapeutic options. Ann Intern Med 2004, 140:545-553.
53. Quirk M First treatment trial for West Nile infections begins. Lancet Infect Dis 2002, 2:589-590.
54. Solomon T Exotic and emerging viral encephalitides. Curr Opinion Neurol 2003, 16:411-418.
55. Poland JD, Cropp CB, Cravan RB, et al. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 1990, 161:878-882.
56. Drug Facts and Comparisons 1995, 111. JE-VAX Monograph., JB Lippincott, St. Louis. B.R. Olin (Ed.).
57. Luo D, Yin H, Xili L, et al. The efficacy of Japanese encephalitis vaccine in Henan, China: A case-control study. Southeast Asian J Trop Med Public Health 1994, 24:643-646.
58. Hennessy S, Liu Z, Tsai TF, et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SAI4-14-2): A case-control study. Lancet 1996, 347:1583-1586.
59. Bista MB, Banerjee MK, Shin SH, et al. Efficacy of single-dose encephalitis: A case control study. Lancet 2001, 358:791-795.
60. Lai CJ, Monath TP Chimeric flaviviruses: Novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv Virus Res 2003, 61:469-509.
61. Monath TP, Guirakhoo F, Nichols R, et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 2003, 188:1213-1230.
62. Immunization for Japanese Encephalitis 1971, Igaku Shoin, Tokyo. W.M. Hammon, M. Kitaoka, W.G. Downs (Eds.).
63. Komada K, Sasaki N, Inoue YK Studies of live attenuated Japanese encephalitis vaccine in swine. Immunol 1968, 100:194-200.
64. Hall RA, Khromykh AA West Nile vaccines. Expert Opin Biol Ther 2004, 8:1295-1305.
65. Lieberman M, Tesh R, Clements D: A recombinant subunit vaccine protects against fatal West Nile encephalitis hamsters. Proceedings of the Viral Vaccine Meeting, Abstract LB11, Barcelona, Spain, 2003.
66. Monath TP, Arroyo J, Miller C, et al. West Nile virus vaccine. Curr Drug Targets Infect Disord 2001, 1:37-50.
67. Gubler DJ, Campbell GL, Nasci R, et al. West Nile virus in the United States: Guidelines for detection, prevention, and control. Viral Immunol 2000, 13:469-475.
68. Russell RC, Dwyer DE Arboviruses associated with human disease in Australia. Microbes Infect 2000, 14:1693-1704.
69. de Souza Lopes O, de Abreu Sacchetta L, Coimbra TL, et al. Emergence of a new arbovirus disease in Brazil. II. Epidemiologic studies on 1975 epidemic. Am J Epidemiol 1978, 108:394-401.
70. Figueiredo LTM The Brazilian flaviviruses. Microbes Infect 2000, 13:1643-1649.
71. Banerjee K Kyasanur Forest disease. The Arboviruses: Epidemiology and Ecology 1988, 3:93-116. CRC Press, Boca Raton, FL. T.P. Monath (Ed.).
72. Pavri K Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease. Rev Infect Dis 1989, 11(Suppl 4):S854-S859.
73. Monlun E, Zeller H, Le Guenno B, et al. Surveillance of the circulation of arbovirus of medical interest in the region of eastern Senegal. Bull Soc Pathol Exot 1993, 86:21-28.
74. Dandawate CN, Upadhyaya S, Banerjee K Serological response to formalized Kyasanur Forest disease virus vaccine in humans at Sagar and Sorab taluks of Shirnoga district. Biol Stand 1980, 8:1.